190 related articles for article (PubMed ID: 38380551)
1. DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis.
Xu S; Yuan Z; Jiang C; Chen W; Li Q; Chen T
Adv Sci (Weinh); 2024 Apr; 11(16):e2308531. PubMed ID: 38380551
[TBL] [Abstract][Full Text] [Related]
2. YAP/TAZ activation mediates PQ-induced lung fibrosis by sustaining senescent pulmonary epithelial cells.
Yu Y; Chu C; Wang K; Li Y; Mao Z; Hu L; Wang J; Yu Y; Sun H; Chen F
Respir Res; 2024 May; 25(1):212. PubMed ID: 38762455
[TBL] [Abstract][Full Text] [Related]
3. Uncovering the relationship between YAP/ WWTR1 (TAZ) genes expression and LncRNAs of SNHG15, HCP5 and LINC01433 in breast cancer tissues.
Beyrami M; Khodadadi I; Tavilani H; Razavi ANE; Karimi J
Pathol Res Pract; 2024 May; 257():155286. PubMed ID: 38599044
[TBL] [Abstract][Full Text] [Related]
4. TRIM21-mediated ubiquitylation of TAT suppresses liver metastasis in gallbladder cancer.
Wu Z; Zhang J; Jia Z; Yang Z; Liu S; Wang H; Zhao C; Zhao J; Tang Q; Xiong Y; Yang Y; Zhang Y; Zhou Z; Yue J; Xiao F; Sun Q; Gong A; Yao W; Li H; Song X; Ye Y; Zhu Y; Dong P; Ma F; Wu X; Gong W
Cancer Lett; 2024 Jun; 592():216923. PubMed ID: 38697462
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy.
Xu S; Jiang C; Lin R; Wang X; Hu X; Chen W; Chen X; Chen T
J Exp Clin Cancer Res; 2021 Nov; 40(1):373. PubMed ID: 34823564
[TBL] [Abstract][Full Text] [Related]
6. circLIFR-007 reduces liver metastasis via promoting hnRNPA1 nuclear export and YAP phosphorylation in breast cancer.
Zhang Y; Tan Y; Yuan J; Tang H; Zhang H; Tang Y; Xie Y; Wu L; Xie J; Xiao X; Li Y; Kong Y
Cancer Lett; 2024 Jun; 592():216907. PubMed ID: 38685451
[TBL] [Abstract][Full Text] [Related]
7. FOXA2 suppresses gallbladder carcinoma cell migration, invasion, and epithelial-mesenchymal transition by targeting SERPINB5.
Hong L; Chen M; Huang M; Chen W; Abudukeremu X; She F; Chen Y
Environ Toxicol; 2024 Feb; 39(2):708-722. PubMed ID: 37665156
[TBL] [Abstract][Full Text] [Related]
8. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.
Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J
J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation of RUNX3 promotes the progression of gallbladder cancer through repressing SLC7A11-mediated ferroptosis.
Cai C; Zhu Y; Mu J; Liu S; Yang Z; Wu Z; Zhao C; Song X; Ye Y; Gu J; Sang Y; Wu X; Gong W
Cell Signal; 2023 Aug; 108():110710. PubMed ID: 37156453
[TBL] [Abstract][Full Text] [Related]
10. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-ι/GLI1 pathway.
Tian L; Deng Z; Xu L; Yang T; Yao W; Ji L; Lu Y; Zhang J; Liu Y; Wang J
Cell Death Dis; 2018 Nov; 9(11):1115. PubMed ID: 30389910
[TBL] [Abstract][Full Text] [Related]
12. A YAP-centered mechanotransduction loop drives collective breast cancer cell invasion.
Khalil AA; Smits D; Haughton PD; Koorman T; Jansen KA; Verhagen MP; van der Net M; van Zwieten K; Enserink L; Jansen L; El-Gammal AG; Visser D; Pasolli M; Tak M; Westland D; van Diest PJ; Moelans CB; Roukens MG; Tavares S; Fortier AM; Park M; Fodde R; Gloerich M; Zwartkruis FJT; Derksen PW; de Rooij J
Nat Commun; 2024 Jun; 15(1):4866. PubMed ID: 38849373
[TBL] [Abstract][Full Text] [Related]
13. Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.
Cui H; Wang L; Gong P; Zhao C; Zhang S; Zhang K; Zhou R; Zhao Z; Fan H
PLoS One; 2015; 10(4):e0123926. PubMed ID: 25874772
[TBL] [Abstract][Full Text] [Related]
14. Multi-Functional Regulation by YAP/TAZ Signaling Networks in Tumor Progression and Metastasis.
Thrash HL; Pendergast AM
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835395
[TBL] [Abstract][Full Text] [Related]
15. Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression.
Lee DG; Lee SH; Kim JS; Park J; Cho YL; Kim KS; Jo DY; Song IC; Kim N; Yun HJ; Park YJ; Lee SJ; Lee HG; Bae KH; Lee SC; Shim S; Kim YM; Kwon YG; Kim JM; Lee HJ; Min JK
J Hepatol; 2015 Dec; 63(6):1429-39. PubMed ID: 26292259
[TBL] [Abstract][Full Text] [Related]
16. Glycochenodeoxycholate promotes the metastasis of gallbladder cancer cells by inducing epithelial to mesenchymal transition via activation of SOCS3/JAK2/STAT3 signaling pathway.
Wang H; Zhan M; Liu Q; Wang J
J Cell Physiol; 2020 Feb; 235(2):1615-1623. PubMed ID: 31347168
[TBL] [Abstract][Full Text] [Related]
17. MYC and DNMT3A-mediated DNA methylation represses microRNA-200b in triple negative breast cancer.
Pang Y; Liu J; Li X; Xiao G; Wang H; Yang G; Li Y; Tang SC; Qin S; Du N; Zhang H; Liu D; Sun X; Ren H
J Cell Mol Med; 2018 Dec; 22(12):6262-6274. PubMed ID: 30324719
[TBL] [Abstract][Full Text] [Related]
18. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA lncGALM increases risk of liver metastasis in gallbladder cancer through facilitating N-cadherin and IL-1β-dependent liver arrest and tumor extravasation.
Li H; Hu Y; Jin Y; Zhu Y; Hao Y; Liu F; Yang Y; Li G; Song X; Ye Y; Xiang S; Gao Y; Zhu J; Zhang Y; Jiang L; Huang W; Zhu J; Wu X; Liu Y
Clin Transl Med; 2020 Nov; 10(7):e201. PubMed ID: 33252861
[TBL] [Abstract][Full Text] [Related]
20. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
